Relief Therapeutics Holding SA Key word Personnel Relief Therapeutics Announces CEO Transition 22Nov2023 0840 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely resp
Relief Therapeutics Holding SA Key word Miscellaneous Relief Therapeutics Announces that more than 400000 of its ADRs are currently outstanding and that as a result the Company has achieved an Import
Relief Therapeutics Announces CHF 15 Million Private Placement
26.07.2021 / 07:00
Relief or the
Company ), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced that it has entered into a definitive agreement with two U.S. institutional investors to purchase in a private placement an aggregate of 71,428,572 shares of Relief common stock at a purchase price of CHF 0.21 per share. The aggregate gross proceeds from the private placement are expected to be approximately CHF 15 million, before deducting the placement agent fees and offering expenses payable by Relief. The private placement offering is expected to close on or about July 28, 2021, subject to the satisfaction of customary closing conditions.